Miki Yamaguchi

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Mitochondrial respiratory dysfunctions of alveolar macrophages in interstitial lung disease: an exploratory study of bioenergetic and clinical links.

Mitochondrial respiratory dysfunctions of alveolar macrophages in interstitial lung disease: an exploratory study of bioenergetic and clinical links.

Journal: Frontiers in medicine

Published: October 06, 2025

A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells.

A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells.

Journal: International journal of molecular sciences

Published: June 26, 2024

Esophagomediastinal fistula during durvalumab plus tremelimumab with chemotherapy in angiotensin-converting enzyme 2-positive non-small cell lung cancer: a case report.

Esophagomediastinal fistula during durvalumab plus tremelimumab with chemotherapy in angiotensin-converting enzyme 2-positive non-small cell lung cancer: a case report.

Journal: Translational lung cancer research

Published: May 21, 2024

Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival.

Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival.

Journal: International journal of molecular sciences

Published: May 01, 2024

Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells.

Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells.

Journal: Biochemical and biophysical research communications

Published: August 02, 2023

Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma.

Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma.

Journal: Experimental cell research

Published: January 29, 2023

Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.

Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.

Journal: Biochemical and biophysical research communications

Published: September 01, 2022

Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations.

Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations.

Journal: Experimental cell research

Published: December 20, 2021

MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells.

MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells.

Journal: Experimental cell research

Published: April 14, 2021

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells.

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells.

Journal: Molecular cancer therapeutics

Published: March 06, 2021

Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.

Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.

Journal: Journal of virology

Published: September 08, 2020

Pericyte-myofibroblast transition in the human lung.

Pericyte-myofibroblast transition in the human lung.

Journal: Biochemical and biophysical research communications

Published: April 13, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026